0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

PACAP and VIP

Session 2: New targets: Neuropeptides and ion channels

Debbie Hay

Professor at Department of Pharmacology and Toxicology, University of Otago, New Zealand

Download presentation

Next

Targeting ion channels

You Might Also Like

Related Embedded Video Item Thumbnail Epidemiological and clinical aspects
Related Embedded Video Item Thumbnail Discrepancy between the recommendations and reimbursement regulations of the anti-CGRPs in the Nordics
Related Embedded Video Item Thumbnail Genetic aspects and latest findings
Related Embedded Video Item Thumbnail Combination therapy and switching
Related Embedded Video Item Thumbnail Societal burden of migraine

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128